Author:
Creutzig Ursula,Kutny Matthew,Schlenk Richard F.
Publisher
Springer International Publishing
Reference65 articles.
1. Abrahamsson J, Forestier E, Heldrup J, Jahnukainen K, Jonsson OG, Lausen B, Palle J, Zeller B, Hasle H (2011) Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate. J Clin Oncol 29:310–315
2. August KJ, Aplenc R, Sung L, Raimondi SC, Hirsch BA, Horan JT, Alonzo TA, Gerbing RB, Wang YJ, Kahwash S, Heerema-McKenney A, Meshinchi S, Gamis AS (2014) Adolescents and Young Adults (AYA) with Acute Myeloid Leukemia (AML) have increased treatment-related mortality with similar outcomes – a report from the Children’s Oncology Group Trials AAML03P1 and AAML0531. Blood (ASH abstract), 124
3. Bacher U, Kern W, Schnittger S, Hiddemann W, Haferlach T, Schoch C (2005) Population-based age-specific incidences of cytogenetic subgroups of acute myeloid leukemia. Haematologica 90:1502–1510
4. Baker KS, Bhatia S, Bunin N, Nieder M, Dvorak CC, Sung L, Sanders JE, Kurtzberg J, Pulsipher MA (2011) NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: state of the science, future directions. Biol Blood Marrow Transplant 17:1424–1427
5. Benjamin S, Kroll ME, Cartwright RA, Clough JV, Gorst DW, Proctor SJ, Ross JR, Taylor PR, Wheatley K, Whittaker JA, Stiller CA (2000) Haematologists’ approaches to the management of adolescents and young adults with acute leukaemia. Br J Haematol 111:1045–1050